The comparison of the Wnt signaling pathway inhibitor delivered electrospun nanoyarn fabricated with two methods for the application of urethroplasty

Abstract

Urethral strictures were common disease caused by over-expression of extracellular matrix from fibroblast. In this study, we compare two nanoyarn scaffolds for improving fibroblasts infiltration without inhibition the over-expression of extracellular matrix. Collagen/poly(L-lactide-co-caprolactone) (Col/P(LLA-CL)) nanoyarn scaffolds were prepared by conjugated electrospinning and dynamic liquid electrospinning, respectively. In addition, co-axial electrospinning technique was combined with the nanoyarn fabrication process to produce nanoyarn scaffolds loading Wnt signaling pathway inhibitor. The mechanical properties of the scaffolds were examined and morphology was observed by SEM. Cell morphology, proliferation and infiltration on the scaffolds were investigated by SEM, MTT assay and H&E staining, respectively. The release profiles of different scaffolds were determined using HPLC. The results indicated that cells showed an organized morphology along the nanoyarns and considerable infiltration into the nanoyarn scaffolds prepared by dynamic liquid electrospinning (DLY). It was also observed that the DLY significantly facilitate cell proliferation. The D-DLY could facilitate the infiltration of the fibroblasts and could be a promising scaffold for the treatment of urethra stricture while it may inhibit the collagen production.

Keywords

biomaterials / nanoyarn / electrospinning / inhibitor

References

[1] van der Veer W M, Bloemen M C, Ulrich M M, . Potential cellular and molecular causes of hypertrophic scar formation. Burns, 2009, 35(1): 15–29

[2] Zhang H, Ran X, Hu C L, . Therapeutic effects of liposome-enveloped Ligusticum chuanxiong essential oil on hypertrophic scars in the rabbit ear model. PLoS One, 2012, 7(2): e31157

[3] Zhang K, Guo X, Zhao W, . Application of Wnt pathway inhibitor delivering scaffold for inhibiting fibrosis in urethra strictures: in vitro and in vivo study. International Journal of Molecular Sciences, 2015, 16(11): 27659–27676

[4] Qi L, Song W, Liu Z, . Wnt3a promotes the vasculogenic mimicry formation of colon cancer via Wnt/β-catenin signaling. International Journal of Molecular Sciences, 2015, 16(8): 18564–18579

[5] Tan J, Tong B-D, Wu Y-J, . MicroRNA-29 mediates TGFβ1-induced extracellular matrix synthesis by targeting wnt/β-catenin pathway in human orbital fibroblasts. International Journal of Clinical and Experimental Pathology, 2014, 7(11): 7571–7577

[6] Baarsma H A, Spanjer A I, Haitsma G, . Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease. PLoS One, 2011, 6(9): e25450

[7] Bergmann C, Akhmetshina A, Dees C, . Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Annals of the Rheumatic Diseases, 2011, 70(12): 2191–2198

[8] Conidi A, van den Berghe V, Huylebroeck D. Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling. International Journal of Molecular Sciences, 2013, 14(4): 6690–6719

[9] Park K, Lee K, Zhang B, . Identification of a novel inhibitor of the canonical Wnt pathway. Molecular and Cellular Biology, 2011, 31(14): 3038–3051

[10] Beyer C, Reichert H, Akan H, . Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Annals of the Rheumatic Diseases, 2013, 72(7): 1255–1258

[11] Chuang P Y, Menon M C, He J C. Molecular targets for treatment of kidney fibrosis. Journal of Molecular Medicine, 2013, 91(5): 549–559

[12] Hao S, He W, Li Y, . Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. Journal of the American Society of Nephrology, 2011, 22(9): 1642–1653

[13] Langer R, Vacanti J P. Tissue engineering. Science, 1993, 260(5110): 920–926

[14] Zhang Y, Venugopal J R, El-Turki A, . Electrospun biomimetic nanocomposite nanofibers of hydroxyapatite/chitosan for bone tissue engineering. Biomaterials, 2008, 29(32): 4314–4322

[15] Wu J, Liu S, He L, . Electrospun nanoyarn scaffold and its application in tissue engineering. Materials Letters, 2012, 89: 146–149

[16] Xu Y, Wu J, Wang H, . Fabrication of electrospun poly(L-lactide-co-ε-caprolactone)/collagen nanoyarn network as a novel, three-dimensional, macroporous, aligned scaffold for tendon tissue engineering. Tissue Engineering Part C: Methods, 2013, 19(12): 925–936

[17] Di Lullo G A, Sweeney S M, Korkko J, . Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. The Journal of Biological Chemistry, 2002, 277(6): 4223–4231

[18] Kim B S, Mooney D J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends in Biotechnology, 1998, 16(5): 224–230

[19] Baker B M, Handorf A M, Ionescu L C, . New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Review of Medical Devices, 2009, 6(5): 515–532

[20] Huang C, Chen R, Ke Q, . Electrospun collagen-chitosan-TPU nanofibrous scaffolds for tissue engineered tubular grafts. Colloids and Surfaces B: Biointerfaces, 2011, 82(2): 307–315

[21] Grover C N, Cameron R E, Best S M. Investigating the morphological, mechanical and degradation properties of scaffolds comprising collagen, gelatin and elastin for use in soft tissue engineering. Journal of the Mechanical Behavior of Biomedical Materials, 2012, 10: 62–74

[22] Ji W, Sun Y, Yang F, . Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharmaceutical Research, 2011, 28(6): 1259–1272

[23] Mirdailami O, Soleimani M, Dinarvand R, . Controlled release of rhEGF and rhbFGF from electrospun scaffolds for skin regeneration. Journal of Biomedical Materials Research Part A, 2015, 103(10): 3374–3385

[24] Baker B M, Handorf A M, Ionescu L C, . New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Review of Medical Devices, 2009, 6(5): 515–532

[25] Lee H J, Lee S J, Uthaman S, . Biomedical applications of magnetically functionalized organic/inorganic hybrid nanofibers. International Journal of Molecular Sciences, 2015, 16(6): 13661–13677

[26] Li X Y, Li Y C, Yu D G, . Fast disintegrating quercetin-loaded drug delivery systems fabricated using coaxial electrospinning. International Journal of Molecular Sciences, 2013, 14(11): 21647–21659

[27] Stout D A. Recent advancements in carbon nanofiber and carbon nanotube applications in drug delivery and tissue engineering. Current Pharmaceutical Design, 2015, 21(15): 2037–2044

[28] Bonkat G, Braissant O, Rieken M, . Comparison of the roll-plate and sonication techniques in the diagnosis of microbial ureteral stent colonisation: results of the first prospective randomised study. World Journal of Urology, 2013, 31(3): 579–584

[29] Lv Y. Nanofiber-based drug design, delivery and application. Current Pharmaceutical Design, 2015, 21(15): 1918–1919

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg